Here’s a jaw-dropping revelation: New York City’s public hospitals are funneling millions of dollars into the coffers of Palantir, a company notorious for its ties to ICE and the military. But here’s where it gets controversial—while Palantir is known for enabling mass deportations and surveillance, it’s now dipping its toes into healthcare, raising alarms about privacy, ethics, and the intersection of profit and public welfare.
Since 2023, the New York City Health and Hospitals Corporation has paid Palantir nearly $4 million to streamline its billing processes, particularly for Medicaid and other public benefits. The company’s software scans patient health notes to maximize charges, a practice that, while aimed at efficiency, has sparked concerns about the commodification of healthcare. And this is the part most people miss—Palantir’s role in healthcare isn’t just about numbers; it’s about access to sensitive patient data, including protected health information (PHI).
Palantir’s history is a tangled web of controversy. From its involvement in the NSA’s XKEYSCORE surveillance program to its partnership with the Israeli military during the Gaza conflict, the company has been a lightning rod for criticism. But it’s the firm’s work with U.S. Immigration and Customs Enforcement (ICE) that has activists up in arms. Palantir’s case management software is a linchpin in ICE’s operations, helping to track and deport immigrants—a fact that has many questioning why a company with such a track record should be entrusted with New Yorkers’ medical data.
‘It’s unacceptable that a company targeting our neighbors for deportation is also handling our hospitals’ software,’ said Kenny Morris of the American Friend Service Committee. This sentiment is echoed by Beth Haroules of the New York Civil Liberties Union, who warns that sharing personal health data with Palantir puts lives at risk, especially for immigrant communities already vulnerable to federal scrutiny.
Here’s the kicker: Palantir’s contract allows it to ‘de-identify’ patient data, a process critics argue is far from foolproof. Research shows that re-identifying anonymized data is often trivial, raising fears that sensitive information could fall into the wrong hands. This has led to calls for New York City to sever ties with Palantir, with advocates like Jonathan Westin of the Climate Organizing Hub arguing that the company’s presence undermines trust in the healthcare system.
The debate doesn’t stop there. Palantir’s CEO, Alex Karp, a vocal critic of New York City’s democratic socialist Mayor Zohran Mamdani, adds another layer of complexity. With the mayor’s office holding significant influence over the Health and Hospitals Corporation, the contract raises questions about political motivations and corporate accountability.
But here’s the real question: Should a company with a history of facilitating warfare, deportations, and surveillance be allowed to profit from public healthcare? And what does this say about the priorities of our institutions? As Hannah Drummond of National Nurses United puts it, ‘Palantir has no place in our hospitals.’
This isn’t just a New York issue—it’s a global one. Palantir’s contracts with the U.K.’s National Health Service have faced similar backlash, with critics like Green Party leader Zack Polanski calling for transparency and accountability. As the line between public service and private profit blurs, one thing is clear: the stakes couldn’t be higher.
What do you think? Is Palantir’s involvement in healthcare a necessary evil, or a dangerous overreach? Let us know in the comments—this is a conversation that demands your voice.
